Disclosure Panels Details Page
Chronic Myeloid Leukemia Panel - Disclosures as of 08/17/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jessica Altman MD | AbbVie, Inc. ALX Oncology Amgen Inc. Aprea Aptos Astellas Pharma US, Inc. BioSight Bristol-Myers Squibb Company Cellectis Fujifilm Corporation Gilead Sciences, Inc. GlycoMimetics, Inc. ImmunoGen, Inc. Kartos Kura Oncology, Inc. MEI Pharma Inc. Rafael |
AbbVie, Inc. Astellas Pharma US, Inc. BlueBird Bio Curio Kura Oncology, Inc. Stemline Syros Pharmaceuticals |
GlycoMimetics, Inc. | None | 04/12/2022 |
| Maria Amaya PhD,MD | None | None | None | None | 04/27/2022 |
| Kebede Begna MD | Mayo Clinic | Novartis Pharmaceuticals Corporation | None | None | 05/06/2022 |
| Ellin Berman MD | Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
Novartis Pharmaceuticals Corporation | None | None | 05/31/2022 |
| Ravi Bhatia MD | None | None | None | None | 06/13/2022 |
| Marian Birkeland PhD | None | None | None | None | 07/25/2022 |
| Robert Collins MD | None | Ro5 Inc. | None | None | 05/06/2022 |
| Peter Curtin MD | CRISPR Therapeutics | None | None | None | 05/05/2022 |
| Daniel DeAngelo PhD,MD | AbbVie, Inc. Blueprint Medicines Daiichi- Sankyo Co. GlycoMimetics, Inc. Mt Sinai MPN Consortium |
None | Amgen Inc. Blueprint Medicines Jazz Pharmaceuticals Inc. Kite Pharma Novartis Pharmaceuticals Corporation Pfizer Inc. Servier Takeda Pharmaceuticals North America, Inc. |
None | 01/26/2022 |
| Sarah DeVincenzo BCPS,PharmD | None | None | None | None | 08/11/2022 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 08/08/2022 |
| Jason Gotlib MD,MS | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company Celgene Corporation Cogent Biosciences Deciphera Pharmaceuticals, Inc. Incyte Corporation Kartos PharmaEssentia Promedior, Inc. Protagonist Therapeutics |
AbbVie, Inc. Blueprint Medicines Cogent Biosciences Incyte Corporation PharmaEssentia |
None | None | 05/06/2022 |
| Kristina Gregory OCN,MSN,RN | None | None | None | None | 08/15/2022 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 06/13/2022 |
| Gabriela Hobbs MD | None | AbbVie, Inc. Blueprint Medicines Bristol-Myers Squibb Company Constellation Incyte Corporation Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
None | None | 03/05/2022 |
| Hagop Kantarjian MD | None | None | AbbVie, Inc. Amgen Inc. Astellas Pharma US, Inc. Ipsen Novartis Pharmaceuticals Corporation Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | 07/06/2022 |
| Lori Maness MD | None | None | None | None | 05/18/2022 |
| Monica Mead MD | None | None | None | None | 03/01/2022 |
| Leland Metheny MD | Adienne Pfizer Inc. |
Gamida Incyte Corporation |
None | None | 04/22/2022 |
| Sanjay Mohan MD,MSCI | Incyte Corporation Karyopharm Therapeutics Taiho Pharmaceuticals Co., Ltd. |
None | None | None | 07/24/2022 |
| Joseph Moore MD | Pharmacyclics | None | None | None | 07/22/2022 |
| Vivian Oehler MD | Actuate/Courante Oncology Ascentage Astex Pharmaceuticals Blueprint Medicines Bristol-Myers Squibb Company Cepheid Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | None | 03/17/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 06/21/2022 |
| Keith Pratz MD | AbbVie, Inc. Astellas Pharma US, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. Bristol-Myers Squibb Company Servier |
None | None | 05/05/2022 |
| Iskra Pusic MSCI,MD | GlaxoSmithKline Kadmon Pharmacyclics |
None | None | None | 02/28/2022 |
| Michal Rose MD | None | None | None | None | 07/16/2022 |
| Neil Shah MD,PhD | Aerovate Therapeutics Bristol-Myers Squibb Company PTC Therapeutics Sierra Oncology Taiho Pharmaceuticals Co., Ltd. |
Aerovate Therapeutics | None | None | 05/23/2022 |
| B. Douglas Smith MD | Cellularity | Bristol-Myers Squibb Company CSL-Behring Novartis Pharmaceuticals Corporation Pfizer Inc. Servier |
None | None | 07/11/2022 |
| Hema Sundar PhD | None | None | None | None | 06/27/2022 |
| Bettyanne Sunderland BSN,RN,OCN | None | None | None | None | 06/27/2022 |
| Kendra Sweet MD,MS | AROG Immunogen Incyte Corporation Jazz Pharmaceuticals Inc. |
BerGenBio Bristol-Myers Squibb Company Mablytics Novartis Pharmaceuticals Corporation |
Curio Science | None | 08/09/2022 |
| Moshe Talpaz MD | None | Bristol-Myers Squibb Company Constellation Pharm Novartis Pharmaceuticals Corporation |
None | None | 07/08/2022 |
| Tiffany Tanaka MD | None | None | CTI BioPharma Corp. | None | 08/11/2022 |
| James Thompson MD,MS | Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation |
None | None | None | 04/20/2022 |
| Jennifer Vaughn MSPH,MD | None | None | None | None | 04/28/2022 |
| Jeanna Welborn MD | None | None | None | None | 04/29/2022 |
| David Yang MD | Flambeau Diagnostics | None | None | None | 04/24/2022 |